$EPRX

$6.30▲ -4.4% YTD

3 SEC 13D/G filings tracked · Last updated Oct 15, 2026

Filing History

EPRX ▼ -4.4% - Eupraxia Pharmaceuticals Inc.

CP $6.30▲ -4.4%Oct 15, 2026 · ThinkSabio Blog

$EPRX - Eupraxia Pharmaceuticals Reaches its Enrollment Target for the RESOLVE Trial Investigating EP-104GI for the Treatment of Eosinophilic Esophagi…

News

EPRX ▲ +2.0% - Eupraxia Pharmaceuticals Inc.

CP $8.48▲ +2.0%Sep 30, 2026 · ThinkSabio Blog

$EPRX - Eupraxia Pharmaceuticals Reports 52-Week Data from the Highest Dose Cohort of EP-104GI in its Ongoing Phase 1b/2a RESOLVE Trial for the Treatm…

SEC 13D/G

EPRX - Eupraxia Pharmaceuticals Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks Simplified

$6.66▼ -12.37%Aug 13, 2026 · ThinkSabio Blog

$EPRX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #EPRX Eupraxia Pharmaceuticals Inc. : $6.66 Sector: Healthcare |…